We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK: you should only access these medicines via a medical prescription.
Submissions related to human medicines need to be submitted directly to the MHRA.
Implementing the Artificial Intelligence (AI) White Paper principles.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
MHRA services & information for patients and healthcare professionals.
An MHRA and NICE partnership, funded by Wellcome, is addressing key challenges for regulating and evaluating digital mental health technologies (DMHTs) with input from patients, the public and mental health professionals.
How to package medicines for sale and what information you must provide to consumers and healthcare professionals.
How to apply for, update and cancel licences for the manufacture, import and wholesale of human and veterinary medicines.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
How to contact MHRA for specific services or enquiries.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Further detail on the arrangements giving effect to the Windsor Framework.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Photosensitivity reactions are known side effects of methotrexate treatment and can be severe. Patients should be advised to take precautions to protect their skin in the sun.
Quinine should only be considered when cramps cause regular disruption of sleep.
A joint enforcement notice warns all organisations offering Kenalog as a hayfever treatment to stop advertising it on social media or website advertising
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Disabling, long-lasting or potentially irreversible adverse reactions affecting musculoskeletal and nervous systems have been reported very rarely with fluoroquinolone antibiotics. Fluoroquinolone treatment should be discont…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).